Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the practice gaps as outlined in the specific RFP.
In resource limited settings, antibiotic use in children is common with evidence suggesting both overuse in many settings and underuse in others. Further, differences in usage based on gender and/or class suggest inequities that need to be addressed. Interventions are needed to ensure good stewardship practices are applied to children, one of the most vulnerable populations.
Grant Application due date: July 8, 2021
Geographic Scope: Global
• Only organizations are eligible to receive grants, not individuals or medical practice groups. • The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement. • If the project involves multiple departments within an institution and/or between different institutions / organizations / associations, all institutions must have a relevant role and the requesting organization must have a key role in the project. • For projects offering continuing education credit, the requesting organization must be accredited. • Projects in resource limited settings will be given higher priority
Individual projects requesting up to $25,000 - $100,000 will be considered